Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

RCAS1 Antikörper

Dieses Anti-RCAS1-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von RCAS1 in IHC (p) und FACS. Geeignet für Human.
Produktnummer ABIN1107048

Kurzübersicht für RCAS1 Antikörper (ABIN1107048)

Target

Alle RCAS1 (EBAG9) Antikörper anzeigen
RCAS1 (EBAG9) (Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9))

Reaktivität

  • 57
  • 31
  • 13
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 42
  • 28
  • 2
Maus

Klonalität

  • 43
  • 29
Monoklonal

Konjugat

  • 30
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser RCAS1 Antikörper ist unkonjugiert

Applikation

  • 33
  • 29
  • 20
  • 16
  • 14
  • 13
  • 13
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Klon

22-01-01
  • Spezifität

    This antibody recognizes RCAS1.

    Kreuzreaktivität (Details)

    Species reactivity (tested):Human

    Aufreinigung

    Protein-L Sepharose

    Immunogen

    Human uterine cervical adenocarcinoma cell

    Isotyp

    IgM
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Buffer

    100 μg IgG in 100 μLvolukme of PBS containing 50 % glycerol and 0.5 M NaCl, pH 7.2 No preservative is contained.

    Konservierungsmittel

    Azide free

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store (in aliquots) at -20 °C.
  • Target

    RCAS1 (EBAG9) (Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9))

    Andere Bezeichnung

    EBAG9 / RCAS1

    Hintergrund

    RCAS1 (receptor-binding cancer antigen expressed on SiSo cells) is a novel tumoreassociated antigen expressed in human uterine and ovarian carcinomas. The predicted amino acid sequence of RCAS1 (213 a.a.) possesses an N-terminal transmembrane region and a coiled-coil structure in the C-terminal portion, indicating that RCAS1 is a type II membrane protein able to form oligomers through the coiled-coil structure. RCAS1 revealed different expression pattern from the known tumore associated antigens such as, YH206, GA733, CA125, CEA and sialyl Le molecules in human tumore cell lines. Recent study indicated RCAS1 acts as a ligand for a putative receptor present on various human cells including T, B and NK cells. RCAS1 inhibited the in vitro growth of receptor-expressing cells and induced apoptosis. It was suggested that tumore cells might evade immune surveillance by expression of RCAS1.Synonyms: Cancer-associated surface antigen RCAS1, EB9, Estrogen receptor-binding fragment-associated gene 9 protein, PDAF, Receptor-binding cancer antigen expressed on SiSo cells

    Gen-ID

    9166

    NCBI Accession

    NP_004206

    UniProt

    O00559
Sie sind hier:
Chat with us!